Nanotechnology for targeted therapy of atherosclerosis
S Hossaini Nasr, X Huang - Frontiers in Pharmacology, 2021 - frontiersin.org
Atherosclerosis is the major cause of heart attack and stroke that are the leading causes of
death in the world. Nanomedicine is a powerful tool that can be engineered to target …
death in the world. Nanomedicine is a powerful tool that can be engineered to target …
Biomimetic and bioresponsive nanotherapies for inflammatory vascular diseases
G Yang, J Song, J Zhang - Nanomedicine, 2020 - Taylor & Francis
Cardiovascular diseases (CVDs) remain one of the leading causes of death worldwide [1].
Vascular inflammation is an important pathological fundamental of many CVDs, such as …
Vascular inflammation is an important pathological fundamental of many CVDs, such as …
The effects of particle size, shape, density and flow characteristics on particle margination to vascular walls in cardiovascular diseases
Introduction: Vascular-targeted drug delivery is a promising approach for the treatment of
atherosclerosis, due to the vast involvement of endothelium in the initiation and growth of …
atherosclerosis, due to the vast involvement of endothelium in the initiation and growth of …
In vivo evaluation of vascular-targeted spheroidal microparticles for imaging and drug delivery application in atherosclerosis
Objective: Vascular-targeting remains a promising strategy for improving the diagnosis and
treatment of coronary artery disease (CAD) by providing localized delivery of imaging and …
treatment of coronary artery disease (CAD) by providing localized delivery of imaging and …
Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration
Nanomedicine has great potential in biomedical applications, and specifically in
regenerative medicine and vascular tissue engineering. Designing nanometer-sized …
regenerative medicine and vascular tissue engineering. Designing nanometer-sized …
Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases
Major advances have been achieved in understanding the mechanisms and risk factors
leading to cardiovascular disorders and consequently developing new therapies. A strong …
leading to cardiovascular disorders and consequently developing new therapies. A strong …
[HTML][HTML] Advances in drug delivery to atherosclerosis: Investigating the efficiency of different nanomaterials employed for different type of drugs
Atherosclerosis is the build-up of fatty deposits in the arteries. Atherosclerosis is the main
underlying cause of cardiovascular diseases and the leading cause of global morbidity and …
underlying cause of cardiovascular diseases and the leading cause of global morbidity and …
Multifunctional cell membranes-based nano-carriers for targeted therapies: a review of recent trends and future perspective
M Li, Q Guo, C Zhong, Z Zhang - Drug delivery, 2023 - Taylor & Francis
Nanotechnology has ignited a transformative revolution in disease detection, prevention,
management, and treatment. Central to this paradigm shift is the innovative realm of cell …
management, and treatment. Central to this paradigm shift is the innovative realm of cell …
Nanoparticle functionalization with platelet membrane enables multifactored biological targeting and detection of atherosclerosis
Cardiovascular disease represents one of the major causes of death across the global
population. Atherosclerosis, one of its most common drivers, is characterized by the gradual …
population. Atherosclerosis, one of its most common drivers, is characterized by the gradual …
Targeting therapeutics to the vascular wall in atherosclerosis–carrier size matters
OBJECTIVE: Vascular-targeted imaging and drug delivery systems are promising for the
treatment of atherosclerosis due to the vast involvement of endothelium in the initiation and …
treatment of atherosclerosis due to the vast involvement of endothelium in the initiation and …